Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Veraxa partners with Quadira on ADCs for oncology indications

June 16, 2021

Exelixis and Bristol Myers Squibb agree to study XL-092 with immuno-oncology therapies

June 15, 2021

Vor Biopharma and Abound Bio partner to develop multi-targeted CAR-Ts

June 11, 2021

ONK Therapeutics and Trinity College Dublin collaborate in an Enterprise Ireland funded project

June 10, 2021

Shoreline and BeiGene collaborate to develop and commercialize NK-based cell therapies

June 10, 2021

Sorrento Therapeutics and Karolinska Institutet collaborate on iPSC-derived DAR-NK cells

June 7, 2021

Monopar and the National University of Singapore collaborate on development of MNPR-202

June 4, 2021

Corbus licenses integrin-targeting MAbs, CRB-601 and CRB-602

June 4, 2021

Centivax enters strategic partnership with NMRC for phase I development of Centi-B9

June 3, 2021

Immutep and Merck KGaA collaborate on phase I/II study of eftilagimod alpha plus bintrafusp alfa

June 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...